Retrovirus Testing Market - Global Industry Analysis

Retrovirus Testing Market By Test Type (Infectivity Assay, Product-Enhanced Reverse Transcriptase (PERT) Assay, Co-Cultivation Assay, Transmission Electron Microscopy, Radio-Immune Assay, Western Blot Analysis, Immunofluorescence, Serological Tests), By Technique Type (High-Throughput Screening, Enzyme-Linked Immuno-Sorbent Assay (ELISA), Polymerase Chain Reaction (PCR)), By Sample Type (Blood, Serum, Body Fluids, Cells), By End-User (Hospitals, Clinics, Diagnostic Laboratories & Centers), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028

Published Date: 06-Aug-2022 Category: Healthcare Report Format : PDF Pages: 254 Report Code: ZMR-2403 Status : Published

The global retrovirus testing market size was worth USD 182.4 million in 2021 and is estimated to grow to USD 456.1 million by 2028, with a compound annual growth rate (CAGR) of approximately 16.5 percent during the forecast period.

Description

Retrovirus Testing Market Size And Forecast

The global retrovirus testing market size was worth USD 182.4 million in 2021 and is estimated to grow to USD 456.1 million by 2028, with a compound annual growth rate (CAGR) of approximately 16.5 percent during the forecast period. The report analyzes the retrovirus testing market's drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the retrovirus testing market.

Retrovirus Testing Market: Overview

A retrovirus is a single-stranded RNA virus that contains the reverse transcriptase enzyme. Once a retrovirus enters a host cell, reverse transcriptase helps the retroviral RNA be converted into retroviral DNA. The retrovirus then permits the chromosomal DNA of the host cell to incorporate the retroviral DNA. This integration facilitates retrovirus replication into the host genome, resulting in viral expression. HIV (Human Immunodeficiency Virus) is the most common retrovirus in humans. Other retroviruses that cause human infection involve Human T-cell Lymphotropic Virus-1 (HTLV-1), Human T-cell Lymphotropic Virus-2 (HTLV-2), HIV-1, HIV-2, and others. The rising incidence of HIV and increased awareness about HIV diagnosis drive the global retrovirus testing market. Retrovirus testing tools are one of the most effective tools for disease identification. These tools provide rapid results with high efficacy, enhancing the retrovirus testing industry. The introduction of quick and technologically sophisticated methods for detecting retroviral infections, rising awareness of diagnostic tests, and rising expenditure associated with retrovirus screening are anticipated to drive the global market during the forecast period. The shortage of trained professionals to conduct the assays and the huge costs of retrovirus laboratory testing assay methods and diagnostic kits are expected to impede the market over the forecast period.

COVID-19 Impact:

The COVID-19 outbreak reduced the market share of retrovirus testing. As a result, the demand for HIV diagnostic procedures has significantly decreased, as have patient visits to healthcare facilities, which has negatively impacted the market growth of HIV diagnostics. As the total of COVID-19 patients decreased, demand for HIV diagnostics increased significantly in 2021. Sales of HIV medical testing in low-risk settings also expanded due to medical facilities implementing standard operating procedures and a reduced death rate associated with COVID-19.

Global Retrovirus Testing Market

Key Insights

  • As per the analysis shared by our research analyst, the global retrovirus testing market value will grow at a CAGR of 16.5% over the forecast period.
  • In terms of revenue, the global retrovirus testing market size was valued at around USD 182.4 million in 2021 and is projected to reach USD 456.1 million by 2028.
  • The major factors driving the market's growth are the introduction of rapid and technologically sophisticated methods for detecting retroviral infections, rising awareness of diagnostic tests, and rising expenditure associated with retrovirus screening.
  • By sample type, the blood category dominated the market in 2021.
  • By end user, the diagnostic laboratories & centers segment dominated the market in 2021.
  • By technique type, the high-throughput techniques and PCR-based amplification category dominated the market in 2021.
  • North America dominated the global retrovirus testing market in 2021.

Retrovirus Testing Market: Growth Drivers

Rising government initiatives to increase the number of retrovirus tests to drive market growth

According to WHO, approximately 38 million people worldwide were infected with HIV in 2019. 68% of adults and 53% of children who have contracted the virus are receiving lifetime antiretroviral therapy (ART) as a result of various initiatives by the government and international organizations. Reimbursement policies and supportive government initiatives are additional major factors influencing global retrovirus testing market revenue growth. For instance, the Egyptian government announced in 2020 that it would provide confidential and free HIV diagnostics tests at examination and counseling centers in all 27 governorates. The introduction of rapid and technologically sophisticated methods for detecting retroviral infections, rising awareness of diagnostic tests, and rising costs associated with retrovirus screening are anticipated to drive the global market for retrovirus testing during the forecast period.

Retrovirus Testing Market: Restraints

The lack of skilled professionals to perform the assays and the high cost of retrovirus testing kits hinder the market growth

The lack of trained professionals to perform sensitive assays related to retrovirus testing and the high cost of assay methods & diagnostic kits are factors limiting the growth of the global retrovirus testing market. HIV stigma and the absence of adequate HIV reagents & kits may also limit the growth of the global market.

Retrovirus Testing Market: Segmentation

The global retrovirus testing market has been segmented into test type, technique type, sample type, and end-user.

Based on test type, the market is divided into infectivity assay, product-enhanced reverse transcriptase (PERT) assay, co-cultivation assay, transmission electron microscopy, radio-immune assay, western blot analysis, immunofluorescence, and serological tests. Among these, infectivity assays are the most frequently used method for retrovirus testing in the global market due to the rapid and accurate results obtained from these assays.

Based on technique type, the market is classified into high-throughput screening, enzyme-linked immunosorbent assay (ELISA), and polymerase chain reaction (PCR). In 2021, the high-throughput techniques and PCR category dominated the global market. High-throughput techniques and PCR-based amplification are primarily used in retrovirus testing to detect retrovirus infectious diseases in the target genome with high sensitivity.

Based on sample type, the market is classified into blood, serum, body fluids, and cells. The blood segment dominated the market in 2021, owing to the increased blood transfusions and donations.

Based on end-user, the global retrovirus testing market is segmented into hospitals, clinics, and diagnostic laboratories & centers. The diagnostic laboratories & centers are anticipated to have the highest share in this market. The increased entry of outpatient tests for retroviral testing in early HIV-AIDS diagnosis is fueling the global market growth. High R&D investment and technological advancements also contribute to the diagnostic laboratories segment's revenue growth.

Recent Developments

  • November 2020: The U.S. FDA approved Hologic Inc. for its Retroviral viral load monitoring assay. This has enabled the company to broaden its product offering in the HIV diagnostics market.
  • May 2020: OraSure Technologies Inc. purchased UrSure Inc., a well-known laboratory testing company. This acquisition has expanded the company's HIV diagnostic product offerings.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Retrovirus Testing Market: Regional Landscape

North America dominated the retrovirus testing market in 2021

Due to the increased awareness about retrovirus diagnosis, the existence of well-established healthcare infrastructure, and an increase in investments in activities of research & development, North America dominates the market for retrovirus testing. Moreover, according to HIV.gov statistics published in June 2021, nearly 2 million individuals in the United States have HIV. This suggests that the prevalence of HIV in the nation is high, which will increase demand for its diagnosing products and further propel the regional market. High investment in HIV rapid testing kits research and development contributes significantly to the regional market revenue growth.

Retrovirus Testing Market: Competitive Landscape

Some of the main competitors dominating the global retrovirus testing market include - BGI Genomics, Abbott Diagnostics, Alere Inc, Hybribio Biotech, Roche Diagnostics Ltd, Tellgen Corporation, DiaSorin S.p.A., Dian Diagnostics, bioMerieux SA, Becton, Dickinson & Company, Xilong Scientific.

Global Retrovirus Testing Market is segmented as follows:

By Test Type

  • Infectivity Assay
  • Product-Enhanced Reverse Transcriptase (PERT) Assay
  • Co-Cultivation Assay
  • Transmission Electron Microscopy
  • Radio-Immune Assay
  • Western Blot Analysis
  • Immunofluorescence
  • Serological Tests

By Technique Type

  • High-Throughput Screening
  • Enzyme Linked Immuno-Sorbent Assay (ELISA)
  • Polymerase Chain Reaction (PCR)

By Sample Type

  • Blood
  • Serum
  • Body Fluids
  • Cells

By End User

  • Hospitals
  • Clinics
  • Diagnostic Laboratories & Centers

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Retrovirus Testing Market, (2022 - 2028) (USD Million)
    • 2.2 Global Retrovirus Testing Market : snapshot
  • Chapter 3. Global Retrovirus Testing Market - Industry Analysis
    • 3.1 Retrovirus Testing Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Rising government initiatives to increase the number of retrovirus tests to drive market growth
    • 3.3 Market Restraints
      • 3.3.1. The lack of skilled professionals to perform the assays and the high cost of retrovirus testing kits hinder the market growth
    • 3.4 Market Opportunities
    • 3.5 Market Challenges
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Test Type
      • 3.7.2 Market attractiveness analysis By Technique Type
      • 3.7.3 Market attractiveness analysis By Sample Type
      • 3.7.4 Market attractiveness analysis By End User
  • Chapter 4. Global Retrovirus Testing Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Retrovirus Testing Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Retrovirus Testing Market - Test Type Analysis
    • 5.1 Global Retrovirus Testing Market overview: By Test Type
      • 5.1.1 Global Retrovirus Testing Market share, By Test Type, 2021 and 2028
    • 5.2 Infectivity Assay
      • 5.2.1 Global Retrovirus Testing Market by Infectivity Assay, 2022 - 2028 (USD Million)
    • 5.3 Product-Enhanced Reverse Transcriptase (PERT) Assay
      • 5.3.1 Global Retrovirus Testing Market by Product-Enhanced Reverse Transcriptase (PERT) Assay, 2022 - 2028 (USD Million)
    • 5.4 Co-Cultivation Assay
      • 5.4.1 Global Retrovirus Testing Market by Co-Cultivation Assay, 2022 - 2028 (USD Million)
    • 5.5 Transmission Electron Microscopy
      • 5.5.1 Global Retrovirus Testing Market by Transmission Electron Microscopy, 2022 - 2028 (USD Million)
    • 5.6 Radio-Immune Assay
      • 5.6.1 Global Retrovirus Testing Market by Radio-Immune Assay, 2022 - 2028 (USD Million)
    • 5.7 Western Blot Analysis
      • 5.7.1 Global Retrovirus Testing Market by Western Blot Analysis, 2022 - 2028 (USD Million)
    • 5.8 Immunofluorescence
      • 5.8.1 Global Retrovirus Testing Market by Immunofluorescence, 2022 - 2028 (USD Million)
    • 5.9 Serological Tests
      • 5.9.1 Global Retrovirus Testing Market by Serological Tests, 2022 - 2028 (USD Million)
  • Chapter 6. Global Retrovirus Testing Market - Technique Type Analysis
    • 6.1 Global Retrovirus Testing Market overview: By Technique Type
      • 6.1.1 Global Retrovirus Testing Market share, By Technique Type, 2021 and 2028
    • 6.2 High-Throughput Screening
      • 6.2.1 Global Retrovirus Testing Market by High-Throughput Screening, 2022 - 2028 (USD Million)
    • 6.3 Enzyme Linked Immuno-Sorbent Assay (ELISA)
      • 6.3.1 Global Retrovirus Testing Market by Enzyme Linked Immuno-Sorbent Assay (ELISA), 2022 - 2028 (USD Million)
    • 6.4 Polymerase Chain Reaction (PCR)
      • 6.4.1 Global Retrovirus Testing Market by Polymerase Chain Reaction (PCR), 2022 - 2028 (USD Million)
  • Chapter 7. Global Retrovirus Testing Market - Sample Type Analysis
    • 7.1 Global Retrovirus Testing Market overview: By Sample Type
      • 7.1.1 Global Retrovirus Testing Market share, By Sample Type, 2021 and 2028
    • 7.2 Blood
      • 7.2.1 Global Retrovirus Testing Market by Blood, 2022 - 2028 (USD Million)
    • 7.3 Serum
      • 7.3.1 Global Retrovirus Testing Market by Serum, 2022 - 2028 (USD Million)
    • 7.4 Body Fluids
      • 7.4.1 Global Retrovirus Testing Market by Body Fluids, 2022 - 2028 (USD Million)
    • 7.5 Cells
      • 7.5.1 Global Retrovirus Testing Market by Cells, 2022 - 2028 (USD Million)
  • Chapter 8. Global Retrovirus Testing Market - End User Analysis
    • 8.1 Global Retrovirus Testing Market overview: By End User
      • 8.1.1 Global Retrovirus Testing Market share, By End User, 2021 and 2028
    • 8.2 Hospitals
      • 8.2.1 Global Retrovirus Testing Market by Hospitals, 2022 - 2028 (USD Million)
    • 8.3 Clinics
      • 8.3.1 Global Retrovirus Testing Market by Clinics, 2022 - 2028 (USD Million)
    • 8.4 Diagnostic Laboratories & Centers
      • 8.4.1 Global Retrovirus Testing Market by Diagnostic Laboratories & Centers, 2022 - 2028 (USD Million)
  • Chapter 9. Retrovirus Testing Market - Regional Analysis
    • 9.1 Global Retrovirus Testing Market Regional Overview
    • 9.2 Global Retrovirus Testing Market Share, by Region, 2021 & 2028 (USD Million)
    • 9.3. North America
      • 9.3.1 North America Retrovirus Testing Market, 2022 - 2028 (USD Million)
        • 9.3.1.1 North America Retrovirus Testing Market, by Country, 2022 - 2028 (USD Million)
    • 9.4 North America Retrovirus Testing Market, by Test Type, 2022 - 2028
      • 9.4.1 North America Retrovirus Testing Market, by Test Type, 2022 - 2028 (USD Million)
    • 9.5 North America Retrovirus Testing Market, by Technique Type, 2022 - 2028
      • 9.5.1 North America Retrovirus Testing Market, by Technique Type, 2022 - 2028 (USD Million)
    • 9.6 North America Retrovirus Testing Market, by Sample Type, 2022 - 2028
      • 9.6.1 North America Retrovirus Testing Market, by Sample Type, 2022 - 2028 (USD Million)
    • 9.7 North America Retrovirus Testing Market, by End User, 2022 - 2028
      • 9.7.1 North America Retrovirus Testing Market, by End User, 2022 - 2028 (USD Million)
    • 9.4. Europe
      • 9.4.2 Europe Retrovirus Testing Market, 2022 - 2028 (USD Million)
        • 9.4.2.1 Europe Retrovirus Testing Market, by Country, 2022 - 2028 (USD Million)
    • 9.4 Europe Retrovirus Testing Market, by Test Type, 2022 - 2028
      • 9.4.1 Europe Retrovirus Testing Market, by Test Type, 2022 - 2028 (USD Million)
    • 9.5 Europe Retrovirus Testing Market, by Technique Type, 2022 - 2028
      • 9.5.1 Europe Retrovirus Testing Market, by Technique Type, 2022 - 2028 (USD Million)
    • 9.6 Europe Retrovirus Testing Market, by Sample Type, 2022 - 2028
      • 9.6.1 Europe Retrovirus Testing Market, by Sample Type, 2022 - 2028 (USD Million)
    • 9.7 Europe Retrovirus Testing Market, by End User, 2022 - 2028
      • 9.7.1 Europe Retrovirus Testing Market, by End User, 2022 - 2028 (USD Million)
    • 9.5. Asia Pacific
      • 9.5.3 Asia Pacific Retrovirus Testing Market, 2022 - 2028 (USD Million)
        • 9.5.3.1 Asia Pacific Retrovirus Testing Market, by Country, 2022 - 2028 (USD Million)
    • 9.4 Asia Pacific Retrovirus Testing Market, by Test Type, 2022 - 2028
      • 9.4.1 Asia Pacific Retrovirus Testing Market, by Test Type, 2022 - 2028 (USD Million)
    • 9.5 Asia Pacific Retrovirus Testing Market, by Technique Type, 2022 - 2028
      • 9.5.1 Asia Pacific Retrovirus Testing Market, by Technique Type, 2022 - 2028 (USD Million)
    • 9.6 Asia Pacific Retrovirus Testing Market, by Sample Type, 2022 - 2028
      • 9.6.1 Asia Pacific Retrovirus Testing Market, by Sample Type, 2022 - 2028 (USD Million)
    • 9.7 Asia Pacific Retrovirus Testing Market, by End User, 2022 - 2028
      • 9.7.1 Asia Pacific Retrovirus Testing Market, by End User, 2022 - 2028 (USD Million)
    • 9.6. Latin America
      • 9.6.4 Latin America Retrovirus Testing Market, 2022 - 2028 (USD Million)
        • 9.6.4.1 Latin America Retrovirus Testing Market, by Country, 2022 - 2028 (USD Million)
    • 9.4 Latin America Retrovirus Testing Market, by Test Type, 2022 - 2028
      • 9.4.1 Latin America Retrovirus Testing Market, by Test Type, 2022 - 2028 (USD Million)
    • 9.5 Latin America Retrovirus Testing Market, by Technique Type, 2022 - 2028
      • 9.5.1 Latin America Retrovirus Testing Market, by Technique Type, 2022 - 2028 (USD Million)
    • 9.6 Latin America Retrovirus Testing Market, by Sample Type, 2022 - 2028
      • 9.6.1 Latin America Retrovirus Testing Market, by Sample Type, 2022 - 2028 (USD Million)
    • 9.7 Latin America Retrovirus Testing Market, by End User, 2022 - 2028
      • 9.7.1 Latin America Retrovirus Testing Market, by End User, 2022 - 2028 (USD Million)
    • 9.7. The Middle-East and Africa
      • 9.7.5 The Middle-East and Africa Retrovirus Testing Market, 2022 - 2028 (USD Million)
        • 9.7.5.1 The Middle-East and Africa Retrovirus Testing Market, by Country, 2022 - 2028 (USD Million)
    • 9.4 The Middle-East and Africa Retrovirus Testing Market, by Test Type, 2022 - 2028
      • 9.4.1 The Middle-East and Africa Retrovirus Testing Market, by Test Type, 2022 - 2028 (USD Million)
    • 9.5 The Middle-East and Africa Retrovirus Testing Market, by Technique Type, 2022 - 2028
      • 9.5.1 The Middle-East and Africa Retrovirus Testing Market, by Technique Type, 2022 - 2028 (USD Million)
    • 9.6 The Middle-East and Africa Retrovirus Testing Market, by Sample Type, 2022 - 2028
      • 9.6.1 The Middle-East and Africa Retrovirus Testing Market, by Sample Type, 2022 - 2028 (USD Million)
    • 9.7 The Middle-East and Africa Retrovirus Testing Market, by End User, 2022 - 2028
      • 9.7.1 The Middle-East and Africa Retrovirus Testing Market, by End User, 2022 - 2028 (USD Million)
  • Chapter 10. Company Profiles
    • 10.1 BGI Genomics
      • 10.1.1 Overview
      • 10.1.2 Financials
      • 10.1.3 Product Portfolio
      • 10.1.4 Business Strategy
      • 10.1.5 Recent Developments
    • 10.2 Abbott Diagnostics
      • 10.2.1 Overview
      • 10.2.2 Financials
      • 10.2.3 Product Portfolio
      • 10.2.4 Business Strategy
      • 10.2.5 Recent Developments
    • 10.3 Alere Inc
      • 10.3.1 Overview
      • 10.3.2 Financials
      • 10.3.3 Product Portfolio
      • 10.3.4 Business Strategy
      • 10.3.5 Recent Developments
    • 10.4 Hybribio Biotech
      • 10.4.1 Overview
      • 10.4.2 Financials
      • 10.4.3 Product Portfolio
      • 10.4.4 Business Strategy
      • 10.4.5 Recent Developments
    • 10.5 Roche Diagnostics Ltd
      • 10.5.1 Overview
      • 10.5.2 Financials
      • 10.5.3 Product Portfolio
      • 10.5.4 Business Strategy
      • 10.5.5 Recent Developments
    • 10.6 Tellgen Corporation
      • 10.6.1 Overview
      • 10.6.2 Financials
      • 10.6.3 Product Portfolio
      • 10.6.4 Business Strategy
      • 10.6.5 Recent Developments
    • 10.7 DiaSorin S.p.A.
      • 10.7.1 Overview
      • 10.7.2 Financials
      • 10.7.3 Product Portfolio
      • 10.7.4 Business Strategy
      • 10.7.5 Recent Developments
    • 10.8 Dian Diagnostics
      • 10.8.1 Overview
      • 10.8.2 Financials
      • 10.8.3 Product Portfolio
      • 10.8.4 Business Strategy
      • 10.8.5 Recent Developments
    • 10.9 bioMerieux SA
      • 10.9.1 Overview
      • 10.9.2 Financials
      • 10.9.3 Product Portfolio
      • 10.9.4 Business Strategy
      • 10.9.5 Recent Developments
    • 10.10 Becton
      • 10.10.1 Overview
      • 10.10.2 Financials
      • 10.10.3 Product Portfolio
      • 10.10.4 Business Strategy
      • 10.10.5 Recent Developments
    • 10.11 Dickinson & Company
      • 10.11.1 Overview
      • 10.11.2 Financials
      • 10.11.3 Product Portfolio
      • 10.11.4 Business Strategy
      • 10.11.5 Recent Developments
    • 10.12 Xilong Scientific
      • 10.12.1 Overview
      • 10.12.2 Financials
      • 10.12.3 Product Portfolio
      • 10.12.4 Business Strategy
      • 10.12.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Retrovirus Testing Market, 2022 - 2028 (USD Million)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Retrovirus Testing Market attractiveness, By Test Type
  • 6. Global Retrovirus Testing Market attractiveness, By Technique Type
  • 7. Global Retrovirus Testing Market attractiveness, By Sample Type
  • 8. Global Retrovirus Testing Market attractiveness, By End User
  • 9. Global Retrovirus Testing Market share by Test Type, 2022 and 2028 (USD Million)
  • 10. Global Retrovirus Testing Market by Infectivity Assay, 2022 - 2028 (USD Million)
  • 11. Global Retrovirus Testing Market by Product-Enhanced Reverse Transcriptase (PERT) Assay, 2022 - 2028 (USD Million)
  • 12. Global Retrovirus Testing Market by Co-Cultivation Assay, 2022 - 2028 (USD Million)
  • 13. Global Retrovirus Testing Market by Transmission Electron Microscopy, 2022 - 2028 (USD Million)
  • 14. Global Retrovirus Testing Market by Radio-Immune Assay, 2022 - 2028 (USD Million)
  • 15. Global Retrovirus Testing Market by Western Blot Analysis, 2022 - 2028 (USD Million)
  • 16. Global Retrovirus Testing Market by Immunofluorescence, 2022 - 2028 (USD Million)
  • 17. Global Retrovirus Testing Market by Serological Tests, 2022 - 2028 (USD Million)
  • 18. Global Retrovirus Testing Market share by Technique Type, 2022 and 2028 (USD Million)
  • 19. Global Retrovirus Testing Market by High-Throughput Screening, 2022 - 2028 (USD Million)
  • 20. Global Retrovirus Testing Market by Enzyme Linked Immuno-Sorbent Assay (ELISA), 2022 - 2028 (USD Million)
  • 21. Global Retrovirus Testing Market by Polymerase Chain Reaction (PCR), 2022 - 2028 (USD Million)
  • 22. Global Retrovirus Testing Market share by Sample Type, 2022 and 2028 (USD Million)
  • 23. Global Retrovirus Testing Market by Blood, 2022 - 2028 (USD Million)
  • 24. Global Retrovirus Testing Market by Serum, 2022 - 2028 (USD Million)
  • 25. Global Retrovirus Testing Market by Body Fluids, 2022 - 2028 (USD Million)
  • 26. Global Retrovirus Testing Market by Cells, 2022 - 2028 (USD Million)
  • 27. Global Retrovirus Testing Market share by End User, 2022 and 2028 (USD Million)
  • 28. Global Retrovirus Testing Market by Hospitals, 2022 - 2028 (USD Million)
  • 29. Global Retrovirus Testing Market by Clinics, 2022 - 2028 (USD Million)
  • 30. Global Retrovirus Testing Market by Diagnostic Laboratories & Centers, 2022 - 2028 (USD Million)
  • 31. Global Retrovirus Testing Market share, by Region, 2022 and 2028
  • 32. North America Retrovirus Testing Market, 2022 - 2028 (USD Million)
  • 33. Europe Retrovirus Testing Market, 2022 - 2028 (USD Million)
  • 34. Asia Pacific Retrovirus Testing Market, 2022 - 2028 (USD Million)
  • 35. Latin America Retrovirus Testing Market, 2022 - 2028 (USD Million)
  • 36. The Middle-East and Africa Retrovirus Testing Market, 2022 - 2028 (USD Million)

Table Of Tables

  • 1. Global Retrovirus Testing Market: Snapshot
  • 2. Drivers of the Retrovirus Testing Market: impact analysis
  • 3. North America Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 4. North America Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 5. North America Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 6. North America Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 7. U.S. Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 8. U.S. Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 9. U.S. Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 10. U.S. Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 11. Canada Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 12. Canada Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 13. Canada Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 14. Canada Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 15. Europe Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 16. Europe Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 17. Europe Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 18. Europe Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 19. Germany Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 20. Germany Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 21. Germany Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 22. Germany Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 23. France Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 24. France Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 25. France Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 26. France Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 27. U.K. Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 28. U.K. Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 29. U.K. Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 30. U.K. Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 31. Italy Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 32. Italy Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 33. Italy Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 34. Italy Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 35. Spain Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 36. Spain Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 37. Spain Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 38. Spain Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 39. Rest of Europe Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 40. Rest of Europe Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 41. Rest of Europe Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 42. Rest of Europe Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 43. Asia Pacific Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 44. Asia Pacific Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 45. Asia Pacific Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 46. Asia Pacific Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 47. China Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 48. China Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 49. China Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 50. China Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 51. Japan Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 52. Japan Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 53. Japan Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 54. Japan Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 55. India Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 56. India Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 57. India Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 58. India Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 59. South Korea Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 60. South Korea Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 61. South Korea Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 62. South Korea Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 63. South-East Asia Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 64. South-East Asia Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 65. South-East Asia Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 66. South-East Asia Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 67. Rest of Asia Pacific Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 68. Rest of Asia Pacific Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 69. Rest of Asia Pacific Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 70. Rest of Asia Pacific Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 71. Latin America Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 72. Latin America Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 73. Latin America Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 74. Latin America Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 75. Brazil Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 76. Brazil Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 77. Brazil Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 78. Brazil Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 79. Mexico Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 80. Mexico Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 81. Mexico Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 82. Mexico Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 83. Rest of Latin America Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 84. Rest of Latin America Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 85. Rest of Latin America Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 86. Rest of Latin America Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 87. The Middle-East and Africa Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 88. The Middle-East and Africa Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 89. The Middle-East and Africa Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 90. The Middle-East and Africa Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 91. GCC Countries Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 92. GCC Countries Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 93. GCC Countries Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 94. GCC Countries Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 95. South Africa Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 96. South Africa Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 97. South Africa Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 98. South Africa Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 99. Rest of Middle-East Africa Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 100. Rest of Middle-East Africa Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 101. Rest of Middle-East Africa Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 102. Rest of Middle-East Africa Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)

Methodology

Choose License Type

FrequentlyAsked Questions

Adoption of in-vitro assay methods for retrovirus diagnosis is increasing due to an increase in the incidence of sexually transmissible diseases, as is an investment in research and development, boosting the global retrovirus testing market. The introduction of rapid and technologically sophisticated methods for detecting retroviral infections, rising awareness of diagnostic tests, and rising costs associated with retrovirus screening are anticipated to drive the global market for retrovirus testing during the forecast period.

According to the report, the global retrovirus testing market size was worth USD 182.4 million in 2021 and is estimated to grow to USD 456.1 million by 2028, with a compound annual growth rate (CAGR) of approximately 16.5 percent during the forecast period.

North America is anticipated to continue leading the retrovirus testing market throughout the projected period. The key factors driving the regional market growth are increased awareness about retrovirus diagnosis, well-established healthcare infrastructure, and increased research and development activities investments. Moreover, according to HIV.gov statistics published in June 2021, nearly 2 million individuals in the United States have HIV. This suggests that the prevalence of HIV in the nation is high, which will increase demand for its diagnosing products and further propel the regional market.

Some of the main competitors dominating the global retrovirus testing market include - BGI Genomics, Abbott Diagnostics, Alere Inc, Hybribio Biotech, Roche Diagnostics Ltd, Tellgen Corporation, DiaSorin S.p.A., Dian Diagnostics, bioMerieux SA, Becton, Dickinson & Company, Xilong Scientific.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed